Schlusskurs
Andere Börsenplätze
|
% 5 Tage | % 1. Jan. | ||
168,34 ZAR | -2,29 % |
|
-5,69 % | +2,12 % |
04.09. | Aspen Pharmacare Holdings Limited, 2024 Earnings Call, Sep 04, 2024 | |
04.09. | Afrikanischer Arzneimittelhersteller Aspen in Gesprächen zur Herstellung von Mpox-Impfstoffen | RE |
Umsatz 2024 nach Geschäftsbereichen
Umsatz 2024 nach Geografie
Umsatzverteilungshistorie nach Geschäftssegmenten
Bruttogewinn: Verteilung nach Geschäftssegmenten
Ende d. Geschäftsjahres: Juni | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Medicinal Chemicals and Botanical Products | ||||||||||
Manufacturing | 7,5 Mrd. | 9,89 Mrd. | 10,95 Mrd. | 11,3 Mrd. | 14,14 Mrd. | |||||
Bruttogewinn | 2,26 Mrd. | 2,15 Mrd. | 2,25 Mrd. | 1,29 Mrd. | 1,31 Mrd. | |||||
Pharmaceutical Products | ||||||||||
Commercial Pharmaceuticals - Prescription | - | - | - | - | 11,38 Mrd. | |||||
Bruttogewinn | - | - | - | - | 6,93 Mrd. | |||||
Commercial Pharmaceuticals - OTC | - | - | - | - | 9,71 Mrd. | |||||
Bruttogewinn | - | - | - | - | 5,69 Mrd. | |||||
Commercial Pharmaceuticals - Injectables | - | - | - | - | 9,48 Mrd. | |||||
Bruttogewinn | - | - | - | - | 5,52 Mrd. | |||||
Betriebsergebnis | - | - | - | - | - | |||||
Commercial Pharmaceuticals - Regional Brands | 16,88 Mrd. | 17,18 Mrd. | 17,4 Mrd. | 18,82 Mrd. | - | |||||
Bruttogewinn | 9,04 Mrd. | 9,33 Mrd. | 9,83 Mrd. | 11,23 Mrd. | - | |||||
Other Pharmaceuticals | - | - | - | - | - | |||||
Bruttogewinn | - | - | - | - | - | |||||
Commercial Pharmaceuticals - Sterile Focus Brands | 14,26 Mrd. | 10,69 Mrd. | 10,25 Mrd. | 10,59 Mrd. | - | |||||
Bruttogewinn | 8,04 Mrd. | 6,31 Mrd. | 6,22 Mrd. | 6,42 Mrd. | - | |||||
Commercial | - | - | - | - | - | |||||
Hyperinflationary Economy | - | - | - | - | - | |||||
Latin America (Excluding Hyperinflationary Economy) | - | - | - | - | - | |||||
Europe and Commonwealth of Independent States (CIS) | - | - | - | - | - | |||||
Sub-Saharan Africa | - | - | - | - | - | |||||
Rest of the World | - | - | - | - | - | |||||
Asia Pacific | - | - | - | - | - | |||||
South Africa | - | - | - | - | - | |||||
Vitamins and Nutritional Supplements | ||||||||||
Nutritionals | - | - | - | - | - | |||||
Bruttogewinn | - | - | - | - | - | |||||
Betriebsergebnis | - | - | - | - | - | |||||
Corporate | - | - | - | - | - | |||||
Betriebsergebnis | - | - | - | - | - | |||||
Betriebsergebnis | - | - | - | - | - |
Geografische Umsatzverteilungshistorie
Ende d. Geschäftsjahres: Juni | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Europe CIS | - | 13,62 Mrd. | 13,1 Mrd. | 14,64 Mrd. | 17,6 Mrd. | |||||
Africa Middle East | - | 9,52 Mrd. | 10,28 Mrd. | 8,8 Mrd. | 9,51 Mrd. | |||||
Americas | - | 4,01 Mrd. | 4,3 Mrd. | 5,1 Mrd. | 6,71 Mrd. | |||||
Australasia | 4,62 Mrd. | 5,42 Mrd. | 5,7 Mrd. | 6,55 Mrd. | 6,68 Mrd. | |||||
Asia | - | 5,19 Mrd. | 5,23 Mrd. | 5,62 Mrd. | 4,2 Mrd. | |||||
Abschreibung und Wertminderung | - | - | - | - | - | |||||
Betriebsergebnis | - | - | - | - | - | |||||
United States of America & Canada | 584 Mio. | - | - | - | - | |||||
Other Asia | 1,5 Mrd. | - | - | - | - | |||||
China | 2,94 Mrd. | - | - | - | - | |||||
Japan | - | - | - | - | - | |||||
Developing Europe and CIS | 2,55 Mrd. | - | - | - | - | |||||
Developed Europe | 13,86 Mrd. | - | - | - | - | |||||
Middle East and North Africa | 1,3 Mrd. | - | - | - | - | |||||
Sub-Saharan Africa | 7,88 Mrd. | - | - | - | - | |||||
Abschreibung und Wertminderung | - | - | - | - | - | |||||
Betriebsergebnis | - | - | - | - | - | |||||
International | - | - | - | - | - | |||||
Abschreibung und Wertminderung | - | - | - | - | - | |||||
Betriebsergebnis | - | - | - | - | - | |||||
Latin America | 3,41 Mrd. | - | - | - | - | |||||
Corporate | - | - | - | - | - | |||||
South Africa | - | - | - | - | - | |||||
Abschreibung und Wertminderung | - | - | - | - | - | |||||
Betriebsergebnis | - | - | - | - | - |
- Börse
- Aktien
- APN Aktie
- Finanzen Aspen Pharmacare Holdings Limited
- Geschäftsbereiche

MarketScreener is also available in this country: United States.
Switch edition